All News

Bronchiectasis_342x198_M1200048.jpg

Seropositivity Linked to Bronchiectasis in Rheumatoid Arthritis

Jack Cush, MD

Rheumatoid arthritis associated bronchiectasis (RA-BR) is uncommon, and is unrelated to interstitial lung disease (ILD), but like ILD, can substantially impact RA outcomes.

Read Article
pollution,smoke

Environmental Pollutants Ups Autoimmune Disease Risk

Jack Cush, MD

An Italian environmental study shows that air pollution increases the risk of autoimmune diseases, in particular rheumatoid arthritis, connective tissue diseases (CTDs) and inflammatory bowel diseases (IBD).

Read Article
RA, hands, MCP, deformity

Low Dose IL-2 Efficacy in Rheumatoid Arthritis

Jack Cush, MD

A novel biologic intervention trial has shown that subcutaneous, intermittent therapy with low-dose interleukin-2 (Ld-IL2) is potentially effective and safe in rheumatoid arthritis (RA).

Read Article
undifferentiated,arthritis,early,RA

Undifferentiated Arthritis Does Not Follow an RA Course

Jack Cush, MD

Undifferentiated arthritis (UA) is common in medical practice and many advocate early use of DMARDs; yet a recent study shows that despite DMARD use, UA patients do not fair well with this approach.

Read Article
Pills.JIA_.png

ACR Guidelines for the Treatment of Systemic Juvenile Idiopathic Arthritis

Jack Cush, MD

The ACR has updated its clinical guidelines for the management of juvenile idiopathic arthritis (JIA), with this update focusing on oligoarthritis, TMJ arthritis, and systemic JIA (with and without macrophage activation syndrome); only the latter, systemic JIA recommendations are reported he

Read Article
Dr. Philip Mease on the importance of recognizing fibromyalgia, especially concurrently with rheumatic diseases FM does impact disease severity, esp in RA and AS @RheumNow #RNL2022 https://t.co/cGFYYdf6GU
Robert B Chao, MD doctorRBC ( View Tweet)
Dr. Jonathan Hausman on JIA Most subjects equivalent to adult forms of inflammatory arthritis - note early onset seronegative oligoarthritis Tips on transitioning to adult care - determine extent of active disease vs. chronic damage @RheumNow #RNL2022 https://t.co/MhjH04PQ3e
Robert B Chao, MD doctorRBC ( View Tweet)
Transition programs improve health and QoL of pedi-to-adult rheumatology patients in addition to their autonomy/independence! Dr. @hausmannMD gives both pediatric and adult recommendations to ease care at #RNL2022 @RheumNow https://t.co/e5erQ5nkcE
Dr. Rachel Tate uptoTate ( View Tweet)
Wow.. #JIA patients evolve into different categories over time. Dr Jon Hausmanns talk at #RNL2022 @hausmannMD https://t.co/fefXB2fFmJ
Dr. John Cush RheumNow ( View Tweet)
If you don’t treat active #rheumatoidarthritis while woman 👩 is pregnant, you may do more harm to 👶🏻. Look at the data @UmaMahadevanIBD #RNL2022 @RheumNow https://t.co/6P94IdfS15
Janet Pope Janetbirdope ( View Tweet)
Korean study (TB endemic area) shows the risk of mTB & nontuberculous mycobact infx (NTM) are equal and nearly doubled in RA pts on TNFi. Among 4356 RA (1089 on TNFi) NTM & TB rates were 328- and 341/100K PY (US rate is 6/100K PY) https://t.co/QwzTYt3wX4 https://t.co/GLWreoQ6ih

Links:

Dr. John Cush RheumNow ( View Tweet)
RheumNow Live is Coming to Town! Have you signed up for RheumNow Live yet? We still have space available. https://t.co/FBCQRu32gO https://t.co/KoGR8An6af https://t.co/qtwPbMzqSO

Links:

Dr. John Cush RheumNow ( View Tweet)
ICYMI: Undifferentiated Arthritis Does Not Follow an RA Course UA is common in medical practice and many advocate early use of DMARDs; yet a recent study shows that despite DMARD use, UA patients do not fair well with this approach. https://t.co/l0U4IVAXMG https://t.co/8YPM8DgX8H

Links:

Dr. John Cush RheumNow ( View Tweet)
6780 nonspecific MSK pts (no synovitis) saw 3% w/ CCP+, 45% progressed to IA (RA). Progression seen w/ high CCP (OR 9.4), hand (OR 2.7) & foot pain (OR 4.1). CCP- progress if pain in hands (OR 2.5) or knees. 96% NPV for CCP- w/o hand/foot pain https://t.co/FbDIggQFLJ https://t.co/VtvRUOHTnc

Links:

Dr. John Cush RheumNow ( View Tweet)
Drug Survival Differences in RA, PsA, SpA and PsO https://t.co/aBRhTbVmCM https://t.co/ZDGiKlowoV

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatoid Arthritis and Eosinophilia Considerations when eosinophilia is seen in RA patients. QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas) https://t.co/2FszCiTLgf https://t.co/07uZT2heW3

Links:

Dr. John Cush RheumNow ( View Tweet)
New Download Available! Autoimmune Disease in the USA https://t.co/KvsgBUY7mL https://t.co/PSTF7ma6G6

Links:

Dr. John Cush RheumNow ( View Tweet)
Download this week’s podcast titled “When Less (Drug) is More (Activity) “ https://t.co/FESVNenri9 https://t.co/PVGGjkgcTV

Links:

Dr. John Cush RheumNow ( View Tweet)
French GAZEL study of 20,625 pts showed a confirmed RA Dx was significantly assoc w/ increased CV risk (HR 3.03; 1.13–8.11) independent of usual CV risk factors. RF or ACPA (+) without RA was not associated with CV events https://t.co/DG8o5d9hHE https://t.co/5n9uDAhSrF

Links:

Dr. John Cush RheumNow ( View Tweet)
Postpartum maternal outcomes Study compared 202 RA pts to 596 non-RA controls. There was no difference in infection rates or transfusions, but RA was assoc w/ more preterm births (OR = 2.11). Steroids (41%) were associated with lower birthweight https://t.co/F8DKmEHh0M https://t.co/d4Jkb3huMy

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×